SIS
WST icon

Sound Income Strategies’s West Pharmaceutical WST Stock Holding History

Sound Income Strategies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$253 – 2402
2026
Q1 		$253 Hold
1
– – ﹤0.01% 2454
2025
Q4 		$260 Hold
1
– – ﹤0.01% 2427
2025
Q3 		$264 Hold
1
– – ﹤0.01% 1583
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 1522
2022
Q1 		– Sell
-9
Closed -$4K – 951
2021
Q4 		$4K Buy
+9
New +$3.87K ﹤0.01% 642

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Sound Income Strategies's WST Position: Q2 2026 in Review

Sound Income Strategies sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 1 share — an estimated $253 sold.

Sound Income Strategies first reported a position in WST in Q4 2021 and held it in 5 quarters. The position peaked at $4K in Q4 2021. 565 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Sound Income Strategies reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 1 West Pharmaceutical share in Q2 2026, an estimated $253.
  • Sound Income Strategies first reported a position in West Pharmaceutical in Q4 2021 and held it in 5 quarters.
  • Sound Income Strategies's West Pharmaceutical position peaked at $4K in Q4 2021.
  • 565 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.